VCP
CL icon

Verus Capital Partners’s Colgate-Palmolive CL Stock Holding History

Verus Capital Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-502
Closed -$208K – 288
2022
Q2 		$208K Sell
502
-2,303
-82% -$180K 0.04% 267
2022
Q1 		$216K Buy
+2,805
New +$222K 0.03% 291
2020
Q1 		$82K Sell
1,236
-150
-11% -$10.6K 0.03% 358
2019
Q4 		$95K Buy
+1,386
New +$94.5K 0.03% 397

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verus Capital Partners's CL Position: Q3 2022 in Review

Verus Capital Partners sold out of Colgate-Palmolive (CL) in Q3 2022, closing a stake of 502 shares — an estimated $208K sold.

Verus Capital Partners first reported a position in CL in Q4 2019 and held it in 4 quarters. The position peaked at $216K in Q1 2022. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • Verus Capital Partners reported no remaining Colgate-Palmolive position as of Q3 2022 after selling out during the quarter.
  • Verus Capital Partners sold 502 Colgate-Palmolive shares in Q3 2022, an estimated $208K.
  • Verus Capital Partners first reported a position in Colgate-Palmolive in Q4 2019 and held it in 4 quarters.
  • Verus Capital Partners's Colgate-Palmolive position peaked at $216K in Q1 2022.
  • 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on Verus Capital Partners's 13F filing for Q3 2022, filed 15 Nov 2022.